Analyses with Vision Air are completely traceable and meet the requirements of the FDA 21 CFR part 11 for the pharmaceutical industry. Vision Air is easy to command. Two clicks is all that is ...

The NMU is 21 CFR Part 11 compliant. The company’s Current Good Manufacturing ... with a rapid turnaround time of three weeks ...

Watlow, a US-based industrial heating manufacturer, will preview its Eurotherm branded Edge Process Management platform at ...

Biotechnology and pharmaceutical industries get an accurate, speedy, and flexible ELISA system. In addition to meeting FDA Regulation 21 CFR Part 11, this high-throughput system provides improved ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA ... PM), for eight General snus products. As part of the authorization, the agency granted use of the modified risk claim to reach more ...

(RTTNews) - Biotechnology company Unicycive Therapeutics, Inc. (UNCY) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Oxylanthanum ...

The FDA first reported the outbreak on Aug. 21. The FDA conducted traceback but did not report what food it traced. The agency also conducted sample testing but did not report what was tested.

The first EPM platform solution, EPM Data, will leverage Eurotherm’s advanced data management capabilities to allow ...

Kennedy Jr., who is slated to hold a potentially big role in a new Trump administration, said Wednesday there are “entire departments” within the Food and Drug Administration (FDA) that ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

"Record gold prices generated higher revenues, Adjusted EBITDA and earnings in Q3 compared to Q2 2024," stated Paul Brink, CEO. "GEO sales were stable compared to Q2 although lower compared to Q3 2023 ...